Spacelabs has new corporate web site

Spacelabs Healthcare (Issaquah, Washington) has launched a new corporate web site which it says brings together its entire breadth of products and services available globally. The URL is

Acquisition of Blease Medical in 2005 and Del Mar Reynolds in 2006 expanded the Spacelabs Healthcare portfolio, creating the anesthesia delivery & ventilation and diagnostic cardiology product groups within the company. Details about these products are now easily accessed at the new site along with the patient monitoring & connectivity product family that has been the backbone of the company since its start in 1958 assisting the U.S. Gemini space program with Telemetry solutions.

"This redesigned site represents a new way to help our customers get the information they want quickly and intuitively," said Joseph Davin, president, North American operations. "With our award-winning Service options, Clinician Education and comprehensive product offerings, we are pleased to start out our next 50 years with a fresh new approach to staying connected to our clinical partners."

Spacelabs Healthcare, a subsidiary of OSI Systems, makes medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices.

New DVD to help adults with ADHD

Researchers at the National Technical Institute for the Deaf at Rochester Institute of Technology (Rochester, New York) have developed a DVD that uses American sign language (ASL) and English-based sign language to test for attention deficit hyperactivity disorder (ADHD) in deaf and hard-of-hearing adults.

The test uses an interactive interface to present instructions and items in ASL or in English-based sign language, with optional voicing, along with English captions. Clients view and respond to 54 statements, such as, "I get restless easily," indicating the frequency with which each statement accurately describes them.

deCODE genetics reinstated on Nasdaq

deCODE genetics (Reykjavik, Iceland) said that it has received notice from the the Nasdaq Hearing and Listing Review Council that the listing of the company's common stock will be reinstated to the Nasdaq Global Market effective from the opening of trading on June 29. deCODE's common stock will continue to trade under the symbol DCGN.

The reinstatement follows the Listing Council's reversal of a decision in February by the Nasdaq Listing Qualifications Panel under which the listing of deCODE's common stock was transferred to the Nasdaq Capital Market.